MEET US 2025

DG-GT Meeting: Dresden, DE | 10-11 Mar 2025

|

BIO CHINA 2025: Suzhou, CHN | 13-15 Mar 2025

|

BIO-Europe Spring: Milan, IT | 25-26 Mar 2025

|

German Pharm-Tox Summit: Hannover, DE | 25-28 Mar 2025

|

German Biotech Days: Heidelberg, DE | 09-10 Apr 2025

|

MEET2WIN: Bourdeaux, FR | 06-07 May 2025

|

BIO KOREA 2025: Seoul, KR | 07-09 May 2025

|

BIONNALE 2025: Berlin, DE | 14-15 May 2025

|

Innovation for Cell and Gene Therapies (ICGT): Paris, FR | 22 May 2025

|

MabDesign Partnering Day: Lyon, FR | 02 Jun 2025

|

Congrès Polepharma Biotesting: Evreux, FR | 04-05 Jun 2025

|

International Oligonucleotides and Peptides Conference: Prague, CZ | 09-11 Jun 2025

|

AFI Simposio: Rimini, IT | 11-13 Jun 2025

|

Antibody Industrial Symposium (AIS): Tours, FR | 25-26 Jun 2025

|

CPHI 2025: Frankfurt, DE | 28-30 Oct 2025

News

The revolution in COVID vaccine development

The new COVID-19 vaccine developed by Pfizer/BioNTech was approved by the EMA last December and now Moderna’s is following suit. Both are based on mRNA technology and represent a very different type of vaccine (...)

Batch Testing and Release: Life after Brexit

We at KYMOS and ASPHALION are long-time partners in providing analytical and regulatory services to international pharma and biotech sectors. Our testimony goes beyond the conventional “CRO trading with UK clients” to overcome internalization (...)

Kymos wins Biosuccess Award for consolidation and international expansion as science services company

The awards ceremony was held during the CataloniaBio & HealthTech Gala, shared via live streaming. Judit Anido, president of CataloniaBio & HealthTech: “We need more success stories like Kymos. One of the biggest challenges we (...)

Kymos and Prolytic merge to become Kymos Group

With the German CRO joining the European group, Kymos will strengthen its activity in the biologics and advanced therapies market and broaden its services portfolio while offering three local sites in Europe Barcelona, Spain, (...)